» Articles » PMID: 33596420

Cancer-associated Exportin-6 Upregulation Inhibits the Transcriptionally Repressive and Anticancer Effects of Nuclear Profilin-1

Overview
Journal Cell Rep
Publisher Cell Press
Date 2021 Feb 17
PMID 33596420
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant expression of nuclear transporters and deregulated subcellular localization of their cargo proteins are emerging as drivers and therapeutic targets of cancer. Here, we present evidence that the nuclear exporter exportin-6 and its cargo profilin-1 constitute a functionally important and frequently deregulated axis in cancer. Exportin-6 upregulation occurs in numerous cancer types and is associated with poor patient survival. Reducing exportin-6 level in breast cancer cells triggers antitumor effects by accumulating nuclear profilin-1. Mechanistically, nuclear profilin-1 interacts with eleven-nineteen-leukemia protein (ENL) within the super elongation complex (SEC) and inhibits the ability of the SEC to drive transcription of numerous pro-cancer genes including MYC. XPO6 and MYC are positively correlated across diverse cancer types including breast cancer. Therapeutically, exportin-6 loss sensitizes breast cancer cells to the bromodomain and extra-terminal (BET) inhibitor JQ1. Thus, exportin-6 upregulation is a previously unrecognized cancer driver event by spatially inhibiting nuclear profilin-1 as a tumor suppressor.

Citing Articles

Multiomics Analysis of Exportin Family Reveals XPO1 as a Novel Target for Clear Cell Renal Cell Carcinoma.

Hao Y, Lv H, Yan X, Liang Y, Jiang A, Zhao Y Int J Genomics. 2025; 2025:3645641.

PMID: 39882192 PMC: 11774578. DOI: 10.1155/ijog/3645641.


Analysis of exportins expression unveils their prognostic significance in colon adenocarcinoma: insights from public databases.

Kalia P, Nair R, Yadav S Discov Oncol. 2025; 16(1):21.

PMID: 39776001 PMC: 11711428. DOI: 10.1007/s12672-025-01748-4.


Nuclear transport proteins: structure, function, and disease relevance.

Yang Y, Guo L, Chen L, Gong B, Jia D, Sun Q Signal Transduct Target Ther. 2023; 8(1):425.

PMID: 37945593 PMC: 10636164. DOI: 10.1038/s41392-023-01649-4.


Exploring the mechanism of BK polyomavirus-associated nephropathy through consensus gene network approach.

Sato N, Mori K, Sakai K, Miyata H, Yamamoto S, Kobayashi T PLoS One. 2023; 18(6):e0282534.

PMID: 37319163 PMC: 10270345. DOI: 10.1371/journal.pone.0282534.


Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxel.

Wang H, Teng X, Lin Y, Jiang C, Chen X, Zhang Y Discov Oncol. 2023; 14(1):82.

PMID: 37243787 PMC: 10224898. DOI: 10.1007/s12672-023-00700-8.


References
1.
Finetti P, Cervera N, Charafe-Jauffret E, Chabannon C, Charpin C, Chaffanet M . Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis. Cancer Res. 2008; 68(3):767-76. DOI: 10.1158/0008-5472.CAN-07-5516. View

2.
Wan L, Wen H, Li Y, Lyu J, Xi Y, Hoshii T . ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia. Nature. 2017; 543(7644):265-269. PMC: 5372383. DOI: 10.1038/nature21687. View

3.
Meyer N, Penn L . Reflecting on 25 years with MYC. Nat Rev Cancer. 2008; 8(12):976-90. DOI: 10.1038/nrc2231. View

4.
He N, Liu M, Hsu J, Xue Y, Chou S, Burlingame A . HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol Cell. 2010; 38(3):428-38. PMC: 3085314. DOI: 10.1016/j.molcel.2010.04.013. View

5.
Tang W, Zhou M, Dorsey T, Prieto D, Wang X, Ruppin E . Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival. Genome Med. 2018; 10(1):94. PMC: 6276229. DOI: 10.1186/s13073-018-0602-x. View